Shares of Pfizer PFE rose nearly 3% on Monday following a report issued by Bloomberg, which stated that activist investor Starboard did not nominate any director to Pfizer’s board ahead of Jan. 25.
Ancora, the activist investor, is gearing up for a proxy battle, aiming to replace U.S. Steel’s leadership as it advocates for the company’s shift away from its unsuccessful merger with Nippon ...
Activist investor Starboard is backing down in its fight at Pfizer after seeing little chance of winning board seats or rousing enough shareholder pressure to force out its CEO. A deadline to ...
Some results have been hidden because they may be inaccessible to you